FDA Approves Benicar(R) For The Treatment Of High Blood Pressure In Children And Adolescents Aged 6-16
Links shared publicly online about this topic.
- 1,385total visits
FDA Approves Benicar(R) For The Treatment Of High Blood Pressure In Children And Adolescents Aged 6-16
Daiichi Sankyo, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the hypertension treatment Benicar® (olmesartan medoxomil) for use in children and adolescents 6 to
View full resource at medicalnewstoday.com
Tags: Heart Disease, High Blood Pressure, High Blood Pressure Medication, Drug, Children's Health, FDA, Benicar, Daiichi Sankyo
Most Recently Shared on February 13, 2010 at 6:05 pm By:
FDA Approves Benicar(R) For The Treatment Of High Blood Pressure In Children And Adolescents Aged 6-16 http://mnt.to/3xBV #clinicaltrials
Also Shared By:
FDA Approves Benicar for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16
drugs.com — “Benicar (olmesartan medoxomil) is used to treat hypertension. Includes Benicar side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 12, 2010 at 12:09 am By:
FDA Approves Benicar for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16 - http://bit.ly/95xyxs
Advertisement
MNT Pharma News
@mnt_pharma
FDA Approves Benicar(R) For The Treatment Of High Blood Pressure In Children And Adolescents Aged 6-16 http://mnt.to/3xBV
1 year ago...